Cinveron Stungulyf, lausn 2 mg/ml Ísland - íslenska - LYFJASTOFNUN (Icelandic Medicines Agency)

cinveron stungulyf, lausn 2 mg/ml

williams & halls ehf - ondansetronum hýdróklóríð - stungulyf, lausn - 2 mg/ml

Dengvaxia Evrópusambandið - íslenska - EMA (European Medicines Agency)

dengvaxia

sanofi pasteur - chimeric yellow fever dengue virus serotype 1 (live, attenuated), chimeric yellow fever dengue virus serotype 2 (live, attenuated), chimeric yellow fever dengue virus serotype 3 (live, attenuated), chimeric yellow fever dengue virus serotype 4 (live, attenuated) - fjölmörgum - bóluefni - dengvaxia is indicated for the prevention of dengue disease caused by dengue virus serotypes 1, 2, 3 and 4 in individuals 6 to 45 years of age with test-confirmed previous dengue infection (see sections 4. 2, 4. 4 og 4. notkun dengvaxia ætti að vera í samræmi við opinbera tillögur.

Dolorin Junior Endaþarmsstíll 125 mg Ísland - íslenska - LYFJASTOFNUN (Icelandic Medicines Agency)

dolorin junior endaþarmsstíll 125 mg

williams & halls ehf.* - paracetamolum inn - endaþarmsstíll - 125 mg

Bisbetol Filmuhúðuð tafla 10 mg Ísland - íslenska - LYFJASTOFNUN (Icelandic Medicines Agency)

bisbetol filmuhúðuð tafla 10 mg

williams & halls ehf. - bisoprololum fúmarat - filmuhúðuð tafla - 10 mg

Bisbetol Filmuhúðuð tafla 5 mg Ísland - íslenska - LYFJASTOFNUN (Icelandic Medicines Agency)

bisbetol filmuhúðuð tafla 5 mg

williams & halls ehf. - bisoprololum fúmarat - filmuhúðuð tafla - 5 mg

Broksil Saft 6 mg/ml Ísland - íslenska - LYFJASTOFNUN (Icelandic Medicines Agency)

broksil saft 6 mg/ml

williams & halls ehf.* - ambroxolum hýdróklóríð - saft - 6 mg/ml